DocMorris, a leading company in the fields of online pharmacy, telemedicine and marketplace continues to push ahead with its ‘AI First’ strategy to build an integrated ecosystem of AI-supported services that redefine the patient journey. The October 2025 rollout of the beta phase of the AI-powered health companion in the DocMorris App marked an ongoing shift from a pure service provider to a holistic ‘Health in one click’ ecosystem.
DocMorris simplifies the healthcare experience by bringing symptom checks, telemedicine, pharmacy access, and additional digital services into a single, around-the-clock platform. This approach empowers patients to take control and have a better understanding of their own medical care, transforming them from passive recipients of services into active decision-makers. The DocMorris health companion acts as a central interface and first point of contact for DocMorris customers, offering them an integrated, comprehensive health experience.
For many patients, the journey from experiencing the first symptoms to receiving the correct treatment can be long and challenging. DocMorris bridges this gap by forming strategic partnerships with leading AI companies and adding their solutions to its own healthcare ecosystem. An important component is therefore the cooperation with Infermedica, a global leader in AI-powered symptom analysis and patient triage. Embedding their self-service symptom checker into DocMorris’s offerings will enhance the company’s virtual digital care services, enabling customers to check their symptoms online and receive information on the best next steps, as well as understanding the most probable conditions. Unlike standalone tools, the integration of this certified medical device creates a frictionless loop designed around the patient.
“At DocMorris, we are redefining the patient journey by putting smart technology and convenience at the heart of healthcare. It begins with an AI-driven assessment that carefully analyses your symptoms, providing you with immediate, personalized guidance on the best path forward whether that’s self-care, a video consultation, or an urgent doctor’s visit. By seamlessly integrating these insights with our e-prescription and pharmacy services, we ensure that every patient has instant access to the medication and the professional advice they need”, states David Masó Chief AI Health Officer (CAHO) of DocMorris.
Infermedica’s medically certified virtual triage into the DocMorris app is a powerful step toward more connected, patient-centric care. By combining intelligent triage with DocMorris’ extensive digital offering, including telemedicine and pharmacy services, we can accelerate access to care and help people navigate the healthcare system with clarity and confidence,” adds Piotr Orzechowski, CEO of Infermedica.
More information at: DocMorris App – Medikamente per App kaufen
Media contact Infermedica
Fabian Fröhlich
Email: fabian.froehlich@infermedica.com
Website: www.infermedica.com/de
Infermedica
Infermedica is a global leader in AI-powered symptom analysis and patient triage, dedicated to making healthcare more accessible, accurate, and convenient by automating primary care. Operating in over 30 countries and 26 languages, its solutions have powered over 25 million health checks since 2012.
Media contact DocMorris
Torben Bonnke, Director Communications
Email: media@docmorris.com
Phone: +49 171 864 888 1
DocMorris
DocMorris stands for customer-centred, innovative services and a wide range of digital healthcare products. These range from quickly making appointments to see a doctor online on the TeleClinic telemedicine platform to pharmaceutical advice and the supply of prescription and over-the-counter medicines and healthcare products from Germany’s best-known online pharmacy. In addition, there is the marketplace with a broad complementary range of remedies and aids as well as products from the areas of nutrition, beauty and family. DocMorris thus provides its customers with easy access to comprehensive healthcare services in one place with just one click. In the Germany segment, the Swiss company DocMorris AG generated external sales of CHF 1,122.6million in 2025 with 11 million active customers.